Gilead Sciences (NASDAQ:GILD) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Gilead Sciences beat estimated earnings by 3.27%, reporting an EPS of $1.58 versus an estimate of $1.53.
Revenue was up $43.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.32 which was followed by a 3.61% drop in the share price the next day.
Here’s a look at Gilead Sciences’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.80 | 1.58 | 1.74 | 1.73 |
| EPS Actual | 2.12 | 0.69 | 2.65 | 1.87 |
| Revenue Estimate | 6.28B | 6.64B | 6.25B | 6.07B |
| Revenue Actual | 6.59B | 7.24B | 7.42B | 6.22B |
To track all earnings releases for Gilead Sciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
